Evaluating Established Roles, Future Perspectives and Methodological Heterogeneity for Wilms’ Tumor 1 (WT1) Antigen Detection in Adult Renal Cell Carcinoma, Using a Novel N-Terminus Targeted Antibody (Clone WT49)

Evaluating Established Roles, Future Perspectives and Methodological Heterogeneity for Wilms’ Tumor 1 (WT1) Antigen Detection in Adult Renal Cell Carcinoma, Using a Novel N-Terminus Targeted Antibody (Clone WT49)

Renal cell carcinoma (RCC) is arguably the deadliest form of genitourinary malignancy and is nowadays viewed as a heterogeneous series of cancers, with the same origin but fundamentally different metabolisms and clinical behaviors. Immunohistochemistry (IHC) is increasingly necessary for RCC subtypi...

Full description

Bibliographic Details
Main Authors:	Dorin Novacescu, Talida Georgiana Cut, Alin Adrian Cumpanas, Silviu Constantin Latcu, Razvan Bardan, Ovidiu Ferician, Cosmin-Ciprian Secasan, Andrei Rusmir, Marius Raica
Format:	Article
Language:	English
Published:	MDPI AG 2022-04-01
Series:	Biomedicines
Subjects:	adult renal cell carcinoma Wilms’ tumor 1 WT1 clone WT49 immunohistochemistry molecular pathology
Online Access:	https://www.mdpi.com/2227-9059/10/4/912

Similar Items

Circulating microRNA profiles in Wilms tumour (WT): A systematic review and meta-analysis of diagnostic test accuracy
by: Sara Benlhachemi, et al.
Published: (2023-09-01)

Deducing the stage of origin of Wilms' tumours from a developmental series of Wt1-mutant mice
by: Rachel L. Berry, et al.
Published: (2015-08-01)

Inhibitory effect of curcuminoids on Wilms' tumor1 (WT1) gene and its protein expression
by: S Tima, et al.
Published: (2008-01-01)

High Expression of WT1 and Low Expression of p53 in Archived Blocks of Children with Wilms Tumor in South Western Uganda
by: Ssenkumba B, et al.
Published: (2024-03-01)

Cytotoxicity of WT1-reactive T cells against Wilms tumor: An implication for antigen-specific adoptive immunotherapy
by: Seyed Mostafa Monzavi, et al.
Published: (2023-09-01)

The Role of Ultrasonography for Diagnosing Wilms Tumor in Developing Country
by: Aulia Rahmani, et al.
Published: (2021-07-01)

Comprehensive Biology and Genetics Compendium of Wilms Tumor Cell Lines with Different <i>WT1</i> Mutations
by: Brigitte Royer-Pokora, et al.
Published: (2020-12-01)

Molecular mechanism of Wilms’ tumor (Wt1) (+/−KTS) variants promoting proliferation and migration of ovarian epithelial cells by bioinformatics analysis
by: Xiaomei Wang, et al.
Published: (2023-02-01)

Every Beat You Take—The Wilms′ Tumor Suppressor WT1 and the Heart
by: Nicole Wagner, et al.
Published: (2021-07-01)

Altered VEGF Splicing Isoform Balance in Tumor Endothelium Involves Activation of Splicing Factors Srpk1 and Srsf1 by the Wilms’ Tumor Suppressor Wt1
by: Kay-Dietrich Wagner, et al.
Published: (2019-01-01)

<i>TERT</i> Expression in Wilms Tumor Is Regulated by Promoter Mutation or Hypermethylation, WT1, and N-MYC
by: Carolyn M. Jablonowski, et al.
Published: (2022-03-01)

A Metabonomic View on Wilms Tumor by High-Resolution Magic-Angle Spinning Nuclear Magnetic Resonance Spectroscopy
by: Ljubica Tasic, et al.
Published: (2022-01-01)

Appropriate Amounts and Activity of the Wilms’ Tumor Suppressor Gene, <i>wt1</i>, Are Required for Normal Pronephros Development of <i>Xenopus</i> Embryos
by: Taisei Shiraki, et al.
Published: (2022-10-01)

WT1 expression in the human fetus during development
by: R. Ambu, et al.
Published: (2015-06-01)

Microstructure and Hot Deformation Behavior of the Mg–8 wt.% Sn–1.5 wt.% Al Alloy
by: Zhaoqian Sun, et al.
Published: (2021-04-01)

Shikonin as a WT1 Inhibitor Promotes Promyeloid Leukemia Cell Differentiation
by: Zhenzhen Guo, et al.
Published: (2022-11-01)

WT1: A single gene associated with multiple and severe phenotypes
by: Maria Tereza Martins Ferrari, et al.
Published: (2023-12-01)

Studies of Wilms’ Tumor (WT1) Gene Expression in Adult Acute Leukemias in Singapore
by: Che Kang Lim, et al.
Published: (2007-01-01)

WT1 Trio Peptide-Based Cancer Vaccine for Rare Cancers Expressing Shared Target WT1
by: Yusuke Oji, et al.
Published: (2023-01-01)

Memory discrimination is promoted by the expression of the transcription repressor WT1 in the dentate gyrus
by: Leonardo Munari, et al.
Published: (2023-09-01)

A novel cell-penetrating peptide derived from WT1 enhances p53 activity, induces cell senescence and displays antimelanoma activity in xeno- and syngeneic systems
by: Mariana H. Massaoka, et al.
Published: (2014-01-01)

The Role of Wilms’ Tumor Gene (WT1) Expression as a Marker of Minimal Residual Disease in Acute Myeloid Leukemia
by: Davide Lazzarotto, et al.
Published: (2022-06-01)

WT1 peptide vaccine in Montanide in contrast to poly ICLC, is able to induce WT1-specific immune response with TCR clonal enrichment in myeloid leukemia
by: Hongtao Liu, et al.
Published: (2018-01-01)

New Denoising Method for Lidar Signal by the WT-VMD Joint Algorithm
by: Zhenzhu Wang, et al.
Published: (2022-08-01)

Antitumor effect of oral cancer vaccine with Bifidobacterium delivering WT1 protein to gut immune system is superior to WT1 peptide vaccine
by: Toshiro Shirakawa, et al.
Published: (2018-01-01)

Clinicopathological features of different Histopathological Subtypes and Stages of Wilms Tumor
by: Alia Ahmad, et al.
Published: (2023-04-01)

The importance of IDH1, ATRX and WT-1 mutations in glioblastoma
by: Gülsün Gülten, et al.
Published: (2020-07-01)

Prognostic impact of peripheral blood Wilms’ tumour 1 mRNA expression levels in response to azacytidine in MDS: A single-centre analysis
by: Tomoya Maeda, et al.
Published: (2021-01-01)

Whole exome sequencing identified a rare WT1 loss‐of‐function variant in a non‐syndromic POI patient
by: Yingchen Wang, et al.
Published: (2022-01-01)

Wilms’ Tumor 1 (WT1): The Vaccine for Cancer
by: Kyaw Zaw Hein, et al.
Published: (2020-11-01)

Hemolytic uremic syndrome as the presenting manifestation of WT1 mutation and Denys-Drash syndrome: a case report
by: Joseph L. Alge, et al.
Published: (2017-07-01)

CMIP interacts with WT1 and targets it on the proteasome degradation pathway
by: Shao‐Yu Zhang, et al.
Published: (2021-07-01)

Study of Urinary WT1 Positive Cells as a Biomarker for Detection of Glomerular Diseases
by: Jayesh Saha , Ranjana Solanki , Madan Solanki , Utkarsh Sharma , Suman Meena , Vijaya S Devi, Poonam Arora, Gurvi Chauhan
Published: (2023-08-01)

Wilms’ tumor 1 -targeting cancer vaccine: Recent advancements and future perspectives
by: Masahiro Ogasawara
Published: (2024-12-01)

A WT1-positive pleural neoplasm. Is it always a mesothelioma?
by: G Gaggero, et al.
Published: (2023-09-01)

Frequency and clinical impact of WT1 mutations in the context of CEBPA-mutated acute myeloid leukemia
by: Ting Wang, et al.
Published: (2022-12-01)

The role of adenosine monophosphate-activated protein kinase (AMPK) in the action of modified recombinant extracellular wt (wild-type) ASYN in vitro
by: Jeremić Marija, et al.
Published: (2016-01-01)

PRMT5 regulates ovarian follicle development by facilitating Wt1 translation
by: Min Chen, et al.
Published: (2021-08-01)

The role of WT1 in breast and other cancers: oncogene or tumor suppressor gene?
by: P Graidist
Published: (2009-10-01)

Incidence and Prognostic Impact of WT-1 Gene Exon7 and 9 Mutations in Acute Promyelocytic Leukemia
by: Fatemeh Nejatifar, et al.
Published: (2022-04-01)